Atomistry » Bromine » PDB 4kvh-4my6 » 4kwp
Atomistry »
  Bromine »
    PDB 4kvh-4my6 »
      4kwp »

Bromine in PDB 4kwp: Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution

Enzymatic activity of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution

All present enzymatic activity of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution, PDB code: 4kwp was solved by A.Ranchio, G.Lolli, R.Battistutta, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 36.24 / 1.25
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 58.448, 45.821, 63.486, 90.00, 111.15, 90.00
R / Rfree (%) 13.6 / 17

Bromine Binding Sites:

The binding sites of Bromine atom in the Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution (pdb code 4kwp). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution, PDB code: 4kwp:
Jump to Bromine binding site number: 1; 2; 3; 4;

Bromine binding site 1 out of 4 in 4kwp

Go back to Bromine Binding Sites List in 4kwp
Bromine binding site 1 out of 4 in the Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br408

b:22.9
occ:1.00
 BRE A:EXX408 0.0 22.9 1.0
CAN A:EXX408 1.9 15.4 1.0
CAP A:EXX408 2.8 18.6 1.0
CAL A:EXX408 2.9 18.6 1.0
HE3 A:LYS68 2.9 22.1 1.0
HD2 A:LYS68 3.0 19.1 1.0
HD12 A:ILE174 3.1 14.7 1.0
NAJ A:EXX408 3.2 22.8 1.0
O A:HOH576 3.3 19.4 1.0
HG11 A:VAL53 3.4 20.8 1.0
BRC A:EXX408 3.4 28.4 1.0
O A:HOH744 3.4 34.9 1.0
OD1 A:ASP175 3.5 17.3 1.0
CE A:LYS68 3.6 18.5 1.0
HG21 A:VAL53 3.7 21.4 1.0
CD A:LYS68 3.7 15.9 1.0
HZ2 A:LYS68 3.7 24.9 1.0
CD1 A:ILE174 3.8 12.3 1.0
HG11 A:VAL66 3.8 17.2 1.0
HD13 A:ILE174 3.8 14.7 1.0
HG13 A:VAL53 3.8 20.8 1.0
HG2 A:LYS68 3.9 18.7 1.0
CG1 A:VAL53 4.1 17.3 1.0
HD11 A:ILE174 4.1 14.7 1.0
HG22 A:VAL53 4.1 21.4 1.0
CAM A:EXX408 4.1 18.8 1.0
OD2 A:ASP175 4.1 15.7 1.0
CAQ A:EXX408 4.1 19.9 1.0
CG A:ASP175 4.2 15.6 1.0
NZ A:LYS68 4.2 20.8 1.0
O A:HOH822 4.2 11.3 1.0
CG A:LYS68 4.2 15.6 1.0
CG2 A:VAL53 4.3 17.9 1.0
HG3 A:LYS68 4.4 18.7 1.0
HE2 A:LYS68 4.4 22.1 1.0
HE3 A:MET163 4.5 15.0 0.5
HD3 A:LYS68 4.5 19.1 1.0
HZ1 A:LYS68 4.5 24.9 1.0
HG12 A:VAL66 4.5 17.2 1.0
CAG A:EXX408 4.6 24.3 1.0
CG1 A:VAL66 4.6 14.3 1.0
CAO A:EXX408 4.6 18.1 1.0
HB A:ILE174 4.7 11.3 1.0
HG12 A:VAL53 4.8 20.8 1.0
CB A:VAL53 4.8 15.5 1.0
HZ3 A:LYS68 4.9 24.9 1.0
HG13 A:VAL66 5.0 17.2 1.0

Bromine binding site 2 out of 4 in 4kwp

Go back to Bromine Binding Sites List in 4kwp
Bromine binding site 2 out of 4 in the Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 2 of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br408

b:28.4
occ:1.00
 BRC A:EXX408 0.0 28.4 1.0
CAL A:EXX408 2.0 18.6 1.0
CAM A:EXX408 2.9 18.8 1.0
CAN A:EXX408 2.9 15.4 1.0
O A:HOH822 3.2 11.3 1.0
BRD A:EXX408 3.2 24.5 1.0
HB2 A:PHE113 3.4 13.8 1.0
BRE A:EXX408 3.4 22.9 1.0
HG12 A:ILE95 3.5 13.4 1.0
HG11 A:VAL66 3.5 17.2 1.0
HB A:ILE174 3.6 11.3 1.0
CG A:PHE113 3.7 11.1 1.0
HG21 A:ILE174 3.7 13.0 1.0
HD2 A:LYS68 3.7 19.1 1.0
HB3 A:PHE113 3.7 13.8 1.0
CD2 A:PHE113 3.7 11.7 1.0
HD2 A:PHE113 3.7 14.0 1.0
CB A:PHE113 3.8 11.5 1.0
HB A:VAL66 3.8 16.3 1.0
HD12 A:ILE174 3.8 14.7 1.0
HD13 A:ILE174 3.9 14.7 1.0
HG12 A:VAL66 4.1 17.2 1.0
HG22 A:ILE174 4.1 13.0 1.0
CG1 A:VAL66 4.1 14.3 1.0
CAO A:EXX408 4.2 18.1 1.0
CG2 A:ILE174 4.2 10.9 1.0
CAP A:EXX408 4.3 18.6 1.0
CD1 A:PHE113 4.3 10.8 1.0
CB A:ILE174 4.3 9.4 1.0
CD1 A:ILE174 4.3 12.3 1.0
CE2 A:PHE113 4.4 13.2 1.0
CG1 A:ILE95 4.4 11.2 1.0
HD11 A:ILE95 4.4 15.2 1.0
CB A:VAL66 4.5 13.6 1.0
HG21 A:VAL66 4.6 19.9 1.0
HG3 A:LYS68 4.6 18.7 1.0
CD A:LYS68 4.6 15.9 1.0
HD13 A:ILE95 4.6 15.2 1.0
HG21 A:ILE95 4.7 11.6 1.0
HD1 A:PHE113 4.7 13.0 1.0
CD1 A:ILE95 4.7 12.7 1.0
HE2 A:PHE113 4.8 15.8 1.0
HG13 A:ILE95 4.8 13.4 1.0
OD1 A:ASP175 4.8 17.3 1.0
CAQ A:EXX408 4.8 19.9 1.0
H A:ASP175 4.8 11.4 1.0
CE1 A:PHE113 4.9 12.6 1.0
CZ A:PHE113 4.9 11.9 1.0
HG3 A:MET163 5.0 24.9 0.5
CG1 A:ILE174 5.0 10.5 1.0

Bromine binding site 3 out of 4 in 4kwp

Go back to Bromine Binding Sites List in 4kwp
Bromine binding site 3 out of 4 in the Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 3 of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br408

b:24.5
occ:1.00
 BRD A:EXX408 0.0 24.5 1.0
CAM A:EXX408 1.9 18.8 1.0
CAL A:EXX408 2.8 18.6 1.0
CAO A:EXX408 2.9 18.1 1.0
O A:GLU114 3.0 17.6 1.0
HD11 A:ILE95 3.1 15.2 1.0
HG21 A:VAL66 3.1 19.9 1.0
BRC A:EXX408 3.2 28.4 1.0
BRF A:EXX408 3.3 26.1 1.0
HG23 A:VAL116 3.3 20.6 1.0
H A:VAL116 3.4 19.7 1.0
HA A:HIS115 3.4 17.0 1.0
HB A:VAL66 3.5 16.3 1.0
HD13 A:ILE95 3.7 15.2 1.0
CG2 A:VAL66 3.8 16.6 1.0
HG23 A:VAL66 3.8 19.9 1.0
CD1 A:ILE95 3.8 12.7 1.0
N A:VAL116 3.9 16.4 1.0
HB A:VAL116 4.0 19.0 1.0
HG21 A:ILE174 4.0 13.0 1.0
HG3 A:MET163 4.0 16.8 0.5
HG3 A:MET163 4.0 24.9 0.5
HB2 A:PHE113 4.0 13.8 1.0
HG12 A:ILE95 4.1 13.4 1.0
HG11 A:VAL66 4.1 17.2 1.0
CB A:VAL66 4.1 13.6 1.0
CAN A:EXX408 4.1 15.4 1.0
HB3 A:PHE113 4.1 13.8 1.0
CG2 A:VAL116 4.2 17.1 1.0
C A:GLU114 4.2 13.8 1.0
CA A:HIS115 4.2 14.2 1.0
CAQ A:EXX408 4.3 19.9 1.0
HG21 A:VAL116 4.3 20.6 1.0
HE2 A:MET163 4.4 13.2 0.5
C A:HIS115 4.4 14.6 1.0
CB A:VAL116 4.5 15.9 1.0
CG1 A:ILE95 4.5 11.2 1.0
HD12 A:ILE95 4.6 15.2 1.0
CB A:PHE113 4.6 11.5 1.0
HG22 A:ILE174 4.6 13.0 1.0
CG1 A:VAL66 4.6 14.3 1.0
HG22 A:VAL66 4.6 19.9 1.0
N A:HIS115 4.7 13.7 1.0
CAP A:EXX408 4.7 18.6 1.0
CG2 A:ILE174 4.7 10.9 1.0
CA A:VAL116 4.8 18.7 1.0
HD13 A:ILE174 4.9 14.7 1.0
HG3 A:GLU114 4.9 23.4 1.0
HG13 A:ILE95 4.9 13.4 1.0
HG22 A:VAL116 4.9 20.6 1.0
CG A:MET163 5.0 14.0 0.5
CG A:MET163 5.0 20.8 0.5

Bromine binding site 4 out of 4 in 4kwp

Go back to Bromine Binding Sites List in 4kwp
Bromine binding site 4 out of 4 in the Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 4 of Crystal Structure of Human CK2-Alpha in Complex with A Benzimidazole Inhibitor (K164) at 1.25 A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br408

b:26.1
occ:1.00
 BRF A:EXX408 0.0 26.1 1.0
CAO A:EXX408 1.9 18.1 1.0
HE2 A:MET163 2.4 13.2 0.5
CAM A:EXX408 2.9 18.8 1.0
H A:VAL116 2.9 19.7 1.0
CAQ A:EXX408 2.9 19.9 1.0
O A:VAL116 3.0 19.0 1.0
HG21 A:VAL66 3.2 19.9 1.0
HB A:VAL116 3.3 19.0 1.0
CE A:MET163 3.3 11.0 0.5
BRD A:EXX408 3.3 24.5 1.0
CAT A:EXX408 3.4 36.1 1.0
NAU A:EXX408 3.5 22.9 1.0
HE3 A:MET163 3.5 13.2 0.5
HE1 A:MET163 3.5 13.2 0.5
N A:VAL116 3.7 16.4 1.0
HG3 A:MET163 3.8 16.8 0.5
C A:VAL116 3.9 18.3 1.0
HB2 A:ASN118 3.9 21.9 1.0
HD2 A:HIS115 4.0 29.9 1.0
CG2 A:VAL66 4.1 16.6 1.0
CB A:VAL116 4.1 15.9 1.0
HG3 A:MET163 4.1 24.9 0.5
CA A:VAL116 4.1 18.7 1.0
CAL A:EXX408 4.1 18.6 1.0
CAP A:EXX408 4.2 18.6 1.0
HB3 A:ASN118 4.2 21.9 1.0
CD2 A:HIS115 4.2 25.0 1.0
H A:ASN118 4.2 24.1 1.0
HG23 A:VAL66 4.2 19.9 1.0
HA A:HIS115 4.3 17.0 1.0
OAK A:EXX408 4.3 46.2 1.0
HB3 A:MET163 4.3 17.9 0.5
HG22 A:VAL66 4.4 19.9 1.0
HB3 A:MET163 4.4 15.5 0.5
HE2 A:HIS115 4.4 27.9 1.0
SD A:MET163 4.4 12.3 0.5
NE2 A:HIS115 4.4 23.3 1.0
CG A:MET163 4.5 14.0 0.5
CAI A:EXX408 4.5 39.0 1.0
HE3 A:MET163 4.5 15.0 0.5
HG23 A:VAL116 4.5 20.6 1.0
CB A:ASN118 4.5 18.2 1.0
CAN A:EXX408 4.6 15.4 1.0
SD A:MET163 4.7 23.9 0.5
CG A:MET163 4.7 20.8 0.5
CAG A:EXX408 4.8 24.3 1.0
C A:HIS115 4.8 14.6 1.0
CG2 A:VAL116 4.8 17.1 1.0
CG A:HIS115 4.9 19.9 1.0
O A:HOH866 4.9 39.2 1.0
HG11 A:VAL66 4.9 17.2 1.0
N A:ASN118 5.0 20.1 1.0
CB A:MET163 5.0 12.9 0.5
CA A:HIS115 5.0 14.2 1.0

Reference:

G.Cozza, C.Girardi, A.Ranchio, G.Lolli, S.Sarno, A.Orzeszko, Z.Kazimierczuk, R.Battistutta, M.Ruzzene, L.A.Pinna. Cell-Permeable Dual Inhibitors of Protein Kinases CK2 and Pim-1: Structural Features and Pharmacological Potential. Cell.Mol.Life Sci. V. 71 3173 2014.
ISSN: ISSN 1420-682X
PubMed: 24442476
DOI: 10.1007/S00018-013-1552-5
Page generated: Wed Jul 10 21:54:36 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy